Tumor grading plays a significant role for IDH-mutant diffuse astrocytomas prognosis with grade 3 tumors exhibiting a median OS of 8.1 years, whereas grade 4 tumors have a significantly shorter median OS of 4.7 years (p < 0.05) (31, 32). The gene discussed is IDH2; the disease is neoplasm.